ChineseInvestors.com, Inc. (CIIX) Engages Boustead Securities, LLC for Planned IPO of CBD Biotech
Company has retained Boustead Securities for underwriting of the planned IPO for wholly owned foreign enterprise CBD Biotech CIIX is taking necessary steps to support the growth strategy currently in place for CBD Biotech With the finalized spinoff of CBD Biotech, CIIX will look to refocus on its original mission ChineseInvestors.com, Inc. (OTCQB: CIIX), a leading financial news media and content platform serving the global Chinese-speaking community, recently announced (http://cnw.fm/hu1AA) that it has retained Boustead Securities, LLC for the underwriting of the planned initial public offering (IPO) of its wholly owned foreign enterprise, CBD Biotech Co. Ltd. According to Warren Wang, founder,…